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FibroblastUrodele amphibians can regenerate amputated limbs. It has been considered that differentiated dermal
tissues generate multipotent and undifferentiated cells called blastema cells during limb regeneration. In
early phases of limb regeneration, blastema cells are induced by nerves and the apical epithelial cap (AEC).We
had previously investigated the role of neurotrophic factors in blastema or blastema-like formation consisting
of Prrx-1 positive cells. A new system suitable for investigating early phases of limb regeneration, called the
accessory limb model (ALM), was recently developed. In this study, we performed a comparative
transcriptome analysis between a blastema and wound using ALM. Matrix metalloproteinase (MMP) and
ﬁbroblast growth factor (FGF) signaling components were observed to be predominantly expressed in ALM
blastema cells. Furthermore, we found that MMP activity induced a blastemamarker gene, Prrx-1, in vitro, and
FGF signaling pathways worked in coordination to maintain Prrx-1 expression and ALM blastema formation.
Furthermore, we demonstrated that these two activities were sufﬁcient to induce an ALM blastema in the
absence of a nerve in vivo.arch Core for interdisciplinary
, Okayama, 700-8530, Japan.
).
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Urodele amphibians can regenerate some lost body parts such as
limbs. An amputated limb results in the formation of a regeneration
blastema, which comprises undifferentiated cells known as blastema
cells. The regeneration blastema cells were considered as a homoge-
neous, undifferentiated cell population;however, recent cell fate tracing
experiments have shown that they are a heterogeneous cell population
(Hirata et al., 2010; Kragl et al., 2009). Someblastema cells derived from
muscles remain unipotent. Some blastema cells derived from dermal
tissues can redifferentiate into varied cell type within the connective
tissue lineage during limb regeneration. Induction of suchblastema cells
is unique and important in understanding limb regeneration.
An amputation model would not be appropriate for studying early
events in limb regeneration because amputation causes many
simultaneous reactions in the same area. It is suggested that limb
regeneration triggered by amputation initiates at least two distinct
regenerations to restore missing parts (Satoh et al., 2010b). Regener-
ation of distal structures is dependent on the apical epithelial cap
(AEC), which is the blastema epithelium, whereas regeneration of aproximal structure is independent from the AEC. These two types of
regenerations exhibit distinct gene expression pattern (Satoh et al.,
2010b). Furthermore, histolysis and anti-inﬂammatory responses also
occur after an amputation. Such complex processes make early phases
of limb regeneration difﬁcult to study. A new experimental system
called the accessory limb model (ALM) was recently developed (Endo
et al., 2004; Satoh et al., 2009). This model is based on the results/
insights obtained from previous studies (Egar, 1988; Lheureux, 1977;
Maden and Mustafa, 1984). ALM has two advantages: (1) it can
generate a completely patterned limb by only damage in skin and
nerves. In other words, limb regeneration can be studied using only
these two tissues. (2) ALM is a simpler system for examining early
regeneration reactions than the amputated limb model. A regenerate
using ALM is formed in a single regeneration system, which is called
the AEC-dependent regeneration (Satoh et al., 2010b). A regeneration
blastema in ALM seems not to contain AEC-independent regeneration
in contrast to a blastema in an amputated limb. Furthermore, less
damage is required to induce limb regeneration,minimizing histolysis.
These advantages of ALM make the study of limb regeneration much
simpler. In the early phases of ALM, a deviated nerve is covered by a
migrating epithelium called wound epithelium/epidermis (WE). WE
covers the nerve within several hours (Ferris et al., 2010; Satoh et al.,
2008b; Yang et al., 1999). After the WE migration, nerves and the WE
come in contact with each other. The epithelium overlying the axon
ends is speciﬁed as AEC and is necessary for limb regeneration (Satoh
et al., 2008b). In the presence of AEC and a nerve, ﬁbroblasts can
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AEC nor blastema formation is possible; instead, the wound heals. After
blastema cells are induced, they are thought to undergo redevelopment
to complete limb regeneration (Bryant et al., 2002; Gardiner et al.,
2002). During redevelopment, blastema cells derived from dermal
ﬁbroblasts can differentiate into various cell types, including cartilage
(Hirata et al., 2010; Kragl et al., 2009; Muneoka et al., 1986). However,
the mechanism by which such multipotent blastema cells are induced
remains unknown. Fibroblast activation to become a blastema cell is
believed to takeplaceat nearly the same timeasAEC induction.Actually,
at the very beginning of limb regeneration, nerve involvement, AEC
induction, and ﬁbroblast activation take place almost simultaneously
and in the same area. Therefore, an inclusive understanding of these
three processes is required, and ALM is the best model for studying the
early phases of limb regeneration.
Several developmental genes are re-expressed in a regeneration
blastema, as in adeveloping limbbud.Anapical epidermal ridge (AER) is
formed at the distal region of a developing limb bud in higher
vertebrates, and is considered equivalent to AEC. Furthermore, genes
expressed in AEC are also expressed in AER. Sp-9 is an AEC/AER marker
gene (Kawakami et al., 2004; Satoh et al., 2008b) and is expressed in the
basal layer of the distal blastema epithelium,where Fgf-8 and ﬁbronectin
are also expressed (Critchlow and Hinchliffe, 1994; Han et al., 2001;
Nace and Tassava, 1995). In addition, developmental genes are re-
expressed in blastema mesenchymal cells as well as AEC. For example,
Hoxa-13,which is an autopodmarker inmany vertebrates, is expressed
in the distal region of the blastema (Gardiner et al., 1995; Tamura et al.,
2008; Zakany and Duboule, 2007). Meis genes are regulated in the
proximal region of the blastema, as in the developing limb bud of other
vertebrates (Capdevila et al., 1999; Mercader et al., 1999, 2005). Such
spatiotemporal gene expression patterns strongly suggest that the
blastema is similar in structure to a developing limb bud. However, limb
bud cells are derived from undifferentiated tissue, such as the lateral
platemesoderm,while blastema cells are considered to be derived from
fully differentiated tissues. Therefore, at the very beginning of limb
regeneration, an amputated limb should generate undifferentiated
blastema cells from differentiated cells/tissues. This process is called
“dedifferentiation.” This dedifferentiation appears to be unique and
differs from limb development. Redevelopment begins after blastema
formation (Bryant et al., 2002). Although it is still uncertain whether
later phases of limb regeneration are completely identical to limb
development, studies of limb development have helped us understand
the later phases of limb regeneration. However, because of the unique
nature of the early phases of limb regeneration, there is no choice but to
investigate early phases of limb regeneration. In order to reveal how
urodele amphibians generate blastema cells in the early phase, we
focused on the ﬁbroblast activation in dedifferentiation phase. A
potential marker gene, Prrx-1 (Phox-1, Prx-1, Pmx-1), is expressed
throughout the developing limb bud mesenchyme, and its promoter
region has been used in some transgenic lines to deliver transgenes to
the limb mesenchyme (Kuratani et al., 1994; Leussink et al., 1995;
Martin andOlson, 2000;Nohno et al., 1993). Recently, Prrx-1 expression
pattern, detected from very early stages, was reported in urodele and
anuran limb regeneration (Satoh et al., 2007; Suzuki et al., 2007). As
mentioned above, blastema cells derived from dermal ﬁbroblasts show
multipotency within a connective tissue lineage. Prrx-1 is expressed in
multipotent blastema cells but is not detectable by in situ hybridization
in fully differentiatedﬁbroblasts; therefore, Prrx-1 is considered to be an
ideal marker gene for tracing dermal ﬁbroblast activation in the early
phase of limb regeneration.
We investigated Prrx-1 reactivation using ALM. To gain an
integrated understanding of the early events involved in blastema
formation, we performed a comparative transcriptome analysis of
blastema and lateral skinwounds using ALM. In this analysis, two gene
groups were selected, Fgf signaling components andMMPs. Both have
been suggested to be important regulators of limb regeneration. FGF1and 2 have been identiﬁed as nerve trophic factors (Dungan et al.,
2002; Mullen et al., 1996). FGF8 is well known as an AEC factor in
amphibians (Endo et al., 2000; Han et al., 2001). Fgf-10, which is
expressed in the limb mesenchyme, is a counterpart of Fgf-8.
Disappearance of Fgf-10 expression in limb bud mesenchyme is
correlated with a loss of limb bud regeneration capability in Xenopus
laevis (Yokoyama et al., 2000). MMPs are a necessary component of
limb regeneration (Vinarsky et al., 2005), and their role in regener-
ation is still under debate. We found that these Fgf signaling
components and MMPs were predominantly expressed in ALM at
higher levels than in regular wound. Fgf signaling was necessary for
the maintenance of a blastema but not for the induction of a blastema
marker gene. MMP activity was sufﬁcient to activate Prrx-1 expression
in an axolotl skin culture. Furthermore, we found that such Prrx-
1activation was mediated by β3 integrin and focal adhesion kinase
(FAK). Based on those ﬁndings, we demonstrated that these two
activities could induce blastema-like cells without the inﬂuence of
nerves in vivo.
Materials and methods
Animals and surgery for the induction of accessory limbs
Animals (size 8–12 cm long (nose to tail)) were obtained from
personal breeders. They were housed in an aerated laboratory at
22 °C. Their limbs, which had never previously been subjected to
surgery, were used for ALM surgery. Surgical procedures were
performed as described previously (Endo et al., 2004).
Tissue culture
Axolotl skin was peeled from the forelimbs and/or hind limbs. To
minimize fungal and bacterial contamination, the skin was washed
several times with phosphate-buffered saline (PBS). Then, the skin
was transferred to medium.
In the case of blastema cultures, middle-to-late bud blastemas
from regenerating animalswere harvested and cut into small pieces to
enhance nutrient penetration. At least ﬁve pieces of blastemas were
cultured per well. In case of skin cultures, upper arm/leg skin was
harvested. The size of skin was about 5×5 mm. The culture medium
comprised 70% L-15, 10% fetal bovine serum, 20% sterilized water and
0.2 mg/ml gentamicin. SU5402 (Calbiochem; 16.6 μM), FAK inhibitor
(Sigma; 100 μM), FGF2 (R&D Systems; 0.1 μg/ml), FGF8 (Peprotech;
0.05 μg/ml) and collagenase (Wako; 034–10533) were added as
supplements according to the individual experiment. Skin was
cultured for 48 h and blastemas for 24 h at 28 °Cwithout a CO2 supply.
RT-PCR, sequencing and quantitative RT-PCR (qPCR)
RNA (for use in RT-PCR analysis) was prepared using TriPure
reagent (Roche). ALM samples were harvested at day 5. To collect
blastema samples, the deviated nerve was ﬁrst removed in order to
eliminate nerve-associate cells. Then, blastemas were dissected out
from the upper limbs. With respect to the D5 skin wound (control),
isolated tissues contained the wound epidermis, regenerating dermis
and peripheral skin (epidermis and dermis). Sequencing analysis was
performed using a Roche 454 Sequencing system (Operon). Data were
generated using MIRA software. Quantitative RT-PCR was performed
using the ABI StepOneTM Real-Time PCR System. Data were analyzed
using StepOneTM software version 2.1. Error bars indicate RQmax and
RQmin. The following primers were used:
Ribosomal protein L19 forward, CATGGGCACTGGTAAGAGAAAAG;
Ribosomal protein L19 reverse, GCGGCGCAAGATTCTCAT; Prrx-1
forward, CCCAGACGCCTTTGTAAGAG; Prrx-1 reverse, GGCGAAAC-
TTTGCTCTTCGG; Collagenase forward, ACGAGGCAACAGGGAAAAC;
Table 1
Sequencing analysis using the Roche 454 GS-FLX sequencer.
Contig name Number of read in the library Assigned gene name
D5 blastema D5 wound
As_c8892 10 1 P. waltl for Fibroblast growth
factor receptor 2
As_13892 8 0 P. waltl for Fibroblast growth
factor receptor
As_3208 40 7 Notophthalmus viridescens
Collagenase
As_rep_c2477 187 34 Cynops pyrhogasterStromelysin-1/2a
As_c4539 24 0 Cynops pyrhogasterStromelysin-1/2b
265A. Satoh et al. / Developmental Biology 355 (2011) 263–274Collagenase reverse, -GTGCGTGTGTGTGTGTTTGA; Stromelysin-1/
2a forward, GGAATGGGATTGGTGGAGAC; Stromelysin-1/2a re-
verse, GAGTGGTGGTTGTGGGTGTC; Stromelysin-1/2b forward,
CCTTCCACTCCTGCTGCTAC; Stromelysin-1/2b reverse, GGTCAACG-
CAGTCTTCTTCC; fgf-1 forward,GCGTGCATCTTGGACTTGTA; fgf-1
reverse, TACTCCCCGATGGAAAAGTG; fgf-2 forward, AGGAGC-
GACTCCTGCATAAA; fgf-2 reverse, TGTCCAGTTCGTTTCAGTGC; fgf-
10 forward, GGACTGCCCGTACAGTGTGATGG; fgf-10 reverse,
GTCCTCGCTTGGGAGTTCCTTTC.
Immunohistochemistry and in situ hybridization
Immunohistochemistry and in situ hybridization were performed
as described previously (Satoh et al., 2007). In the case of type I
Collagen andβ3Integrin staining, antigen retrieval was achieved
through incubation with proteinase K (5 μg/ml). The following
antibodies were used in immunohistochemical analyses: anti-type I
Collagen (Sigma; diluted 1:200), anti-phospho-FGFR (Cell Signaling
Tech.; 1:100), anti-phospho-FAK (Cell Signaling Tech.; 1:200), anti-β3
integrin (Cell Signaling Tech.; 1:200), Alexa 488-conjugated anti-
rabbit IgG (Invitrogen; 1:500) and Alexa 596-conjuated anti-mouse
IgG (Invitrogen; 1:500). Nuclei were stained with DAPI (Dojindo).
Images were captured using an Olympus BX51 microscope system.
Western blotting
Whole-cell lysates were prepared using TriPure reagent (Roche) or
lysis buffer (20 mM Tris–HCl (pH 8.0), 1 mM EDTA, 300 mM NaCl,
0.5% NP-40, 1 mM PMSF). Samples were separated by SDS-PAGE and
blotted to nitrocellulose membranes (Bio-Rad). After blocking,
membranes were incubated with the following antibodies: anti-
β3Integrin (Cell Signaling Tech.; diluted 1:1,000), anti-phospho-FAK
(Cell Signaling Tech.; 1:1,000) and anti-γ-tubulin (Sigma; 1:5000).
Blots were washed six times in Tris-buffered saline containing 0.1%
Tween-20 and were then incubated with secondary antibody. Bound
antibody was detected using a chemiluminescent immunoblotting kit
(Rockland). For each sample, the target protein signal was normalized
to that for γ-tubulin in order to correct for differences in protein
loading.
Bead preparation and grafting
Gelatin beads were prepared without CMC (carboxylmethyl
cellurose) as described previously (Tabata et al., 1999). Brieﬂy, gelatin
was dissolved in boiling water to give a 10% solution, which was then
mixed with olive oil to form an oil-gelatin emulsion. This emulsion
was washed with acetone and distilled water. Then, bead particles
were treated overnight with 2 mM glutaraldehyde. The beads were
further agitated in a 10 mM aqueous solution of glycine for at least 1 h
to block the aldehyde groups of residual Glutaraldehyde molecules.
The beads were ﬁnally washed with distilled water several times and
stored at 4 °C. Just before grafting, beads with 300–600 μm diameter
were selected. They were used within a month of preparation.
FGF2 (R&D Systems; 300 ng/μl) and FGF8 (Peprotech, 200 ng/μl)
were adsorbed to the gelatin beads through incubation at 4 °C for at
least 2 h. Control beads were treated with PBS. SU5402 (10 mM) and
GM6001 (10 mM) were incubated with AG1-X2 beads (Bio-Rad).
Wounds (2 mm×2 mm) were made on the upper arms/legs (day 0).
GM6001 soaked Beads were grafted underneath the wounds on days
2, 4, 6 and 8. An incision was created in a 2–5 mm proximal region of
thewound. A tunnel to thewoundwasmade by a forceps and then the
beads were grafted by a tungsten needle. Samples were collected on
day 10.
Induced blastemas by FGFs soaked beads were grafted into a
cartilage regenerating region. This procedure was basically followedprevious report (Satoh et al., 2010a). Induced blastemas were
dissected out by scissors. And the epithelium was removed mechan-
ically by forceps. The bared mesenchymal tissue was labeled by Cell
Tracker Green (Lonza). The blastema mesenchyme was cut into a
small pieces and put into the labeling solution (5 μM) for 30 min at
room temperature. Then the labeled tissues were rinsed by PBT at
least ﬁve times and grafted. Sections were made 20 days after the
surgery.
Results
Fgf signaling is activated in a regenerating blastema and is necessary for
maintaining blastema marker genes
To identify genes active in the early phases of limb regeneration,
we performed a sequence analysis using the Roche 454 GS-FLX
sequencer on a 5-day-old (D5) ALM blastema and D5 simple skin
wound, and obtained 374,904 and 394,743 reads, respectively
(769,647 reads in total). All of these sequences were assembled by
MIRA3 (version 3.0.0), and 36,081 different contigs were obtained.
These contig sequences were subjected to BLASTX and BLASTN
searches against human protein entries found in the NCBI NR database
and Xenopus laevis entries found in the NCBI NR/NT database,
respectively. They were also compared with Ambystoma ESTs using
the BLASTN program. Sequence analysis revealed that ﬁbroblast
growth factor receptors (Fgfrs) were upregulated in D5 ALM blastema
compared to those in D5 simple skin wound (Table 1). The results
were conﬁrmed using quantitative RT-PCR (qPCR) (Fig. 1A, B). qPCR
revealed that Fgfr-1 and -2were expressed at higher levels in D5 ALM
blastema than in D5 simple skin wound (Fig. 1A, B). This is consistent
with the sequence results.
To clarify FGF sources, we focused on nerves, since nerves in a limb
have been suggested to be a source of FGFs (Mullen et al., 1996; Poulin
et al., 1993; Satoh et al., 2008b). Dorsal root ganglia (DRG), which
project axons into the limb, were collected and their Fgf expression
pattern was investigated by RT-PCR (Fig. 1C). Fgf-1 (acidic Fgf), Fgf-2
(basic Fgf),and Fgf-10 were found to be expressed in DRG. This
suggests that the nerve deviating to the wound secretes FGFs in ALM.
At the very beginning in ALM blastema, the deviated nerve is overlaid
by WE during the early phases. To investigate whether WE received
FGFs secreted from the nerves, phosphorylation of FGFRs was
investigated. When the ligands (FGFs) bind to FGFRs, FGFRs are
phosphorylated in order to transduce signals downstream. The basal
layer of WE, where the nerve contacts the epithelium, showed an
intense phosphorylated FGFR signal 3 days after ALM surgery (Fig. 2A,
B). Subsequently, a phosphorylated FGFR signal was detected in the
mesenchyme and basal layer of WE (Fig. 2C, D). To examine whether
SU5402, a FGF-signaling inhibitor, could inhibit phosphorylation of
FGFR, we investigated phosphorylated FGFR expression in the
presence or absence of SU5402 (Fig. 2E–I). ALM blastemas were
induced and SU5402- or PBS-soaked beads were added on day 4.
Samples were ﬁxed on day 5. Control beads (PBS-soaked) did not
Fig. 1. FGF signaling in ALM blastema. (A, B) 454 GS-FLX sequencing analysis was
conﬁrmed by qPCR. (A) Fgfr-1. (B) Fgfr-2. Expression levels were compared between the
induced ALM blastema at day 5 and skin wound at day 5. Fgfr-1 and Fgfr-2 exhibited
higher expression levels in the D5 ALM blastema than in D5 wound. ***Pb0.01. (C) FGF
genes could be detected in DRG. rib=Ribosomal protein as an internal control.
Numbers in the bottom indicate the PCR cycle number.
Fig. 2. FGFR phosphorylation could be detected in ALM at early phases. (A–D)
Phosphorylated FGFR (pFGFR) was visualized by IHC (green). (A, B) At day 3, pFGFR
could be detected primarily in the basal layer of the overlying epithelium. (C, D) At day
5, pFGFR was noticed not only in the basal layer of the epithelium but also in the
mesenchymal region. Asterisks in B and D indicate hematopoietic cells in terms of
histological observation. Arrows in D indicate pFGFR expression in themesenchymal cells.
(E–I) SU5402 treatment decreased in the level of pFGFR expression. (E, F) control beads
grafted ALMblastema at day 5. pFGFR signal (green) could be detected in the epidermis and
mesenchyme as in C and D. (G, H) SU5402 treatment decreased in the expression level of
pFGFR. (I) This inhibition of thephosphorylation of FGFRwas conﬁrmed by thewestern blot
analysis.γ-tubulin is the loading control. Scale bar in (A)=100 μm.Scalebar in (B)=50 μm.
(A, C) and (B,D–H)are thesamemagniﬁcation, respectively.Dotted lines indicate theborder
of the epidermis.
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similar to those shown in Fig. 2C and D (Fig. 2E, F). However,
SU5402 treatment decreased phosphorylated FGFR expression levels
(Fig. 2G, H). These results were conﬁrmed by Western blot analysis
(Fig. 2I). Phosphorylated FGFR expression levels were almost
undetectable in the SU5402-treated ALM blastema cells. These results
suggest that nerves are the source of FGFs during the early phase of
limb regeneration, and that WE and blastema mesenchyme receive
FGFs from the nerves.
To examine the function of Fgf signaling in blastema maintenance,
SU5402was added to a D4 ALMblastema. The gene expression pattern
was examined a day after beads grafting (D5 ALM blastema, Fig. 3). In
the control (DMSO-soaked beads grafted limb), blastema marker
genes—Prrx-1, a blastemamesenchymalmarker gene, and Sp-9, anAEC
marker gene—were not affected and were maintained in the ALM
blastema mesenchyme and AEC, respectively (Fig. 3B, D). In contrast,
SU5402-soaked beads inhibited gene expression. Prrx-1 was down-
regulated, and only a faint signal was detected in a few cells (Fig. 3A,
arrows). Furthermore, Sp-9 was downregulated (Fig. 3C). We
conﬁrmed Prrx-1 regulation by Fgf signaling in the cultured blastema
using qPCR (Fig. 4A). Late bud blastema formed on amputated limbs
were harvested, cut into two pieces, and cultured for 24 h. FGF2 and
8 (FGF2&8) supplement increased Prrx-1 expression compared with
the control (Fig. 4A), while SU5402 treatment decreased Prrx-1
expression. This is consistent with the in vivo experiment (Fig. 3A,B). A blastema,which stops growing, develops a collagenmatrix (Endo
et al., 2004; Satoh et al., 2008a). The above gene expression data
indicate that the blastema is notmaintained properly and stops growing
in the presence of SU5402. Hence, we investigated collagen deposition
using immunohistochemistry in this blastema (Fig. 3E, F). As expected,
collagen was deposited in the SU5402-treated ALM blastema mesen-
chyme (Fig. 3E), and the boundary between AEC and mesenchyme
showed a collagen signal, indicating the development of basal lamina
(arrowheads). In contrast, the growing ALM blastema did not show
much collagen deposition (Fig. 3F, Endo et al., 2004; Satoh et al., 2008a).
This lack of collagen deposition indicated Fgf-signaling related to higher
Fig. 3. FGF signaling is necessary to maintain the D10 ALM blastema. (A–D) Blastema
marker genes were investigated by in situ hybridization. (A) SU5402 decreased Prrx-1
expression in the ALM blastemas. The remaining Prrx-1 expression is shown (arrows).
(B) Control beads did not change Prrx-1 expression. (C) SU5402 application also
decreased in Sp-9 expression in the basal layer of the wound epithelium. (D) Sp-9
expression could be detected in the basal layer of the control (arrowheads). (E, F)
Collagen deposition was visualized by IHC (red). (E) The basal lamina developed in the
SU5402-grafted blastema (arrowheads). (F) Control beads did not stimulate collagen
deposition. Circles in (A–C) indicate grafted beads. Dotted lines in (A–D, F) indicate the
border of the epithelium. Nuclei were visualized by DAPI (blue) in (E) and (F). Scale
bars =100 μm. (A, B) are the same magniﬁcation. (C–F) are the same magniﬁcation.
epi=epidermis.
Fig. 4. qPCR analyses. (A) FGF maintenance blastema gene expressions. The Prrx-1 gene
expression was measured by qPCR. Blastema was dissected and cultured with FGF2 and
8 (left) or SU5402 (right) for 24 h. Control was the cultured blastema. ***Pb0.01 (B)
Three MMP gene expression in blastemas were measured. Blastemas were cultured
with FGF2&8 (white) or SU5402 (dark gray). Light gray bars indicate the control
(blastema culture with no supplement). Fgf inputs maintain MMP gene expressions at
higher level as compared with SU5402 treated samples. ***Pb0.01, nd. = no statistical
difference.
267A. Satoh et al. / Developmental Biology 355 (2011) 263–274MMP activities. To test this possibility, we cultured regular blastemas
with FGF2&8 supplement or SU5402, and then performed RT-PCR in
order to test MMP genes (Fig. 4B). Inhibition of Fgf signaling by SU5402
decreased theMMP gene expression levels (Collagenase, Stromelysin-1a,
and -1b), whereas FGF2&8 supplements maintained MMP activity. This
is consistentwith the result that SU5402-treated ALMblastema showed
higher collagen deposition. These results indicate that FGF signaling
plays an important role in blastema maintenance.Next, we investigated the function of Fgf signaling in Prrx-1
activation. The abovementioned data suggest that Fgf signaling is
necessary for maintaining blastema cells that are already expressing
Prrx-1. Dermal ﬁbroblasts can become blastema cells during the early
phase of limb regeneration (Hirata et al., 2010; Kragl et al., 2009;
Muneoka et al., 1986). We speculated that Fgf signaling had some
functions in Prrx-1 activation in dermal ﬁbroblasts. To examine this,
axolotl limb skin, not blastema, was removed and cultured with
FGF2&8 or SU5402 (Fig. 5A). FGF2&8 application did not enhance
Prrx-1 expression compared to that of the control, although SU5402
decreased its expression. This indicates that FGF2&8 did not function
in Prrx-1 activation in our culture.
Collagenase treatment promoted Prrx-1 expression in vitro
The above data indicate that other candidates induce Prrx-1 before
Fgf signaling acts to maintain the blastema. Our sequence analysis
suggested MMPs as candidates, since MMP genes were more upregu-
lated in the D5 ALM blastema than in the D5 simple skin wound
(Table 1). In early limb regeneration, ﬁbroblasts should be released from
the attached matrix to form an undifferentiated blastema. Extracellular
matrix ECM degradation by MMPs may be involved in the release of
ﬁbroblasts from ECM. As mentioned above, we surveyed our sequence
database and found many contigs annotated as MMP genes. First, we
conﬁrmed sequence data by qPCR (Fig. 6A). Based on this data, we
selected three MMP genes (Collagenase, Stromelysin-1a,and -1b) from
our database. All three MMP genes were upregulated in the D5 ALM
blastema more consistently than in the D5 ALM wound (Fig. 6A). To
investigate MMP function in Prrx-1 activation, a piece of skin was
cultured with collagenase (Fig. 5B). After culturing for 48 h, Prrx-1
expression was observed to be more upregulated than in the control.
Additional FGF2&8 supplement application did not enhance the effect of
collagenase on Prrx-1 activation. This indicates that collagendegradation
plays a role in blastema cell induction.Weexamined Prrx-1 expression in
Fig. 5. (A) FGF2&8 applications to the whole skin culture could not promote Prrx-1
expression. Inhibition of FGF signaling by SU5402 could decrease Prrx-1 expression
level. ***Pb0.01 (B) Collagenase treatment could promote Prrx-1 expression level.
FGF2&8 supplemented with collagenase treatment could not elevate Prrx-1 expression
as compared with simple collagenase-treated samples. ***Pb0.01 (C) The Prrx-1 gene
expression was compared in the blastema and intact skin. Blastema exhibited much
higher Prrx-1 expression levels compared to the Prrx-1 activation by collagenase
application (Fig. 5B).
Fig. 6. (A) Three MMP gene expressions were conﬁrmed by qPCR. White bars indicate
MMP expressions in the D5 blastema. Gray bars indicate MMP expressions in the D5
wound. All three MMPs were upregulated in the D5 blastema. (B) MMPs were
upregulated by bead grafting. The P value was less than 0.01 in all the three genes.
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skin. Prrx-1 expression level in the regular blastema was approximately
8 times more than that in intact skin (Fig. 5C). However, its expression
level in our tissue culture experiment was approximately 2.5 times
greater in collagenase-treated skin than in the control (Fig. 5B). Thismay
be because of suboptimal culture conditions for axolotl cells, since the
ideal cultivation conditions have not been established. Alternatively,
ECM may not be degraded sufﬁciently in vitro to induce a fully Prrx-1
activated state.
FAK phosphorylation and β3 integrin expression pattern are correlated
with ECM degradation
In order to clarify how ECM degradation transduces a cell to
promote Prrx-1 expression, we focused on β3integrin and FAK.
Integrins are links between cells and ECM (Hynes, 2009), and FAK is
autophosphorylated (pFAK) after integrin activation andmediates theintegrin signal into a cell. We ﬁrst investigated β3 integrin and FAK
phosphorylation in cultured skin (Fig. 7A, control). β3 integrin was
detected in cultured normal skin, but not pFAK. To explore whether
collagen degradation activated β3 integrin and pFAK expression, a
piece of axolotl skin was culturedwith collagenase. Skin cultured with
collagenase showed activation of β3 integrin and pFAK expression
(Fig. 7A). This was also observedwhen skinwas culturedwith FGF2&8
supplement and collagenase, although the increase in β3 integrin
expression was slightly higher. When a chemical inhibitor of FAK
phosphorylationwas added to the culturemedia, both β3 integrin and
pFAK expression levels were decreased (Fig. 7A). This suggests that
there is a positive feedback loop from pFAK to β3 integrin. We also
investigated the in vivo expression pattern. Intact skin possessed
some amount of β3 integrin (Fig. 7B1) and pFAK (Fig. 7B2). In
contrast, the regenerating ALM blastema exhibited much higher
immunohistochemical signals for both (Fig. 7B3, B4). The expression
pattern is consistent with Western blot analysis (Fig. 7A). Next we
conﬁrmed that FAK signaling plays a role in Prrx-1 activation. FAK
inhibitor was added to the skin tissue cultured with FGF2&8 and
collagenase (Fig. 7C). Compared with the results shown in Fig. 5B, the
FAK inhibitor successfully suppressed Prrx-1 activation by collage-
nase. These results indicate that β3 integrin activation and FAK
phosphorylation induced by ECM degradation promote Prrx-1
expression in an axolotl skin.FGF-soaked gelatin beads can induce a blastema-like in the absence of a
nerve
The above data clearly indicate that MMP activity and Fgf signaling
plays an important role in Prrx-1 regulation. Therefore, we attempted to
introduce these two in a limb to induce an ALM blastema. Direct
collagenase application, however, resulted in limb deformity because
most of the structural components, such as the dermis, consist of
collagens, and collagenase treatment disrupted these structural colla-
gens. Therefore,wedecided to use a differentmethod.Wehad found that
bead grafting alone elevatedMMP activities in vivo (Fig. 6B). PBS-soaked
Fig. 7. β3 integrinandphosphorylatedFAK (pFAK) expressionpattern. (A)Westernblot analysis.β3 integrinwasupregulated in the collagenase-treated samplesanddownregulated in the
FAK inhibitor-treated samplewith collagenase and FGF-2 and -8 supplements. FAK phosphorylationwasupregulated in the samemanner asβ3 integrin.γ-tubulinwas the loading control.
(B) IHCofβ3 integrin andpFAK inablastema(green). (B1, B2) are the intact skin. (B3,B4) are the regeneratingblastema. (B5, B6) are inducedblastemasbyFGF-2- and FGF-8-soakedbeads.
Nuclei were visualized by DAPI (blue). Scale bars=50 μm. (Bl-6) are the samemagniﬁcation. Dotted lines indicate the border of the epidermis. Asterisk in B5 indicates the grafted gelatin
beads. (C) FAK inhibitor supplement into the skin culture with collagenase treatment inhibits Prrx-1 activation. *Pb0.05.
Table 2
Induction of a blastema under aneurogenic state in the axolotl (Ambystoma
mexicanum).
Blastema induction No. of regeneration Total
FGF2&8 gelatin beads 13 1 14
PBS gelatin beads 4 7a 11
FGF2+8, GM6001 2 14a 16
Simple wound 0 20 20
a A small bump could be seen, but sectioning of the bump revealed only epithelial
growth.
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harvested at D5 in order to test the MMP gene expressions. Three MMP
genes were compared in D5 bead-grafted and simple wounds. All three
MMPswereupregulated in thebead-graftedwound(Fig. 6B).Histological
observation showed that leucocytes, which exhibit higher MMP activity,
gathered around the grafted beads. This gathering of leucocytes may
result in higher MMP activity. Bead grafting can, therefore, act as a
substitute for MMP overexpression. Furthermore, we made another
improvement to thismethod. General beads, which are usually used in
developmental biological experiments, release proteins and/or che-
micals relatively rapidly. Growing a blastema takes a relatively long
time, and hence, release of FGF2&8 supplement, which is applied to
thewound using beads, must be sustained for a long time. Tomaintain
FGF2&8 release for longer periods, we prepared gelatin beads, as
described in the Materials and Methods. We grafted FGF2&8-soaked
gelatin beads instead of general beads. The grafted control PBS-soaked
beads induced “bump” formation in a few cases (Table 2); however,
themajority showed none (Table 2, Fig. 8A). By contrast, grafting with
FGF2&8-soaked beads resulted in a higher rate of bump induction
(Table 2). The induced bump was similar in appearance to an ALM
blastema (Fig. 8B). To examine this further, we sectioned the induced
bump. Histological analysis revealed that ﬁbroblastic cells had
accumulated on the control side (PBS-soaked beads grafted wound),
which suggested that the wound was beginning to heal (Fig. 8C).
Because skinwoundingwithout nerve deviation results in healing and
collagen reorganization (Satoh et al., 2008a), we investigated collagen
deposition (Fig. 8E). Reorganizing collagens were easily visualized
(Fig. 8E). In contrast, FGF2&8-soaked beads grafted into the skin
wound induced relatively compact mononuclear cells, which looked
like typical blastema cells (Fig. 8D). Small round cells were observed
around the beads, which suppressed collagen deposition, similar to aregular growing blastema (Fig. 8F). These results suggested that the
grafted FGF2&8 beads induced a blastema-like cell. We investigated
whether the induced bump was a blastema using molecular marker
genes. Prrx-1 and Sp-9were not detectable on the control side (Fig. 8G,
I); however, theywere clearly expressed in the induced bump (Fig. 8H,
J). Furthermore, β3 integrin expression and pFAK localization patterns
were similar to those of an ALM blastema (Fig. 7B3–B6). These data
indicate that the induced bump has ALM blastema features. We
further conﬁrmed presence of MMP activity in the bump induction.
We applied an MMP inhibitor, GM6001, to an FGF2&8 bead-grafted
wound (Table 2, Fig. 9). In most cases, bump formation was inhibited
(Table 2); however, in some, growth was detected (Fig. 9) and we
further investigated this structure. Sections of the structure showed
that extensional epithelial growth was present (Fig. 9A, B), but in the
mesenchyme, no extension or invasion was observed. We did not
consider this a “bump” since collagen deposition could be seen in the
mesenchyme (Fig. 9C) and Prrx-1 expression was rarely detected
(Fig. 9D). In a few cases, we observed weak Prrx-1 expression in the
bump. Therefore, we determined growth as bump formation (Fig. 9E,
F). GM6001 was not retained on the beads for an extended period of
Fig. 8. Bump induction under the aneurogenic state. (A) Control beads application. No
bump formation was induced by day 10. (B) FGF2 and 8 beads were grafted, resulting in
bump induction by day 10. (C, D) Hematoxylin and eosin staining of (A, B), respectively.
(E, F) collagen deposition made visible by IHC (red). (G–J) Blastemamarker genes were
tested by in situ hybridization. (G, H) Blastema mesenchymal cell marker, Prrx-1. (I, J)
AEC marker gene, Sp-9. Scale bar in (A)=3 mm. Scale bars in (C, E)=200 μm. Dotted
line indicates the border of the grafted beads. (A, B), (C, D), and (E–J) are the same
magniﬁcation, respectively.
Fig. 9. Results of GM6001, FGF2, and FGF8 beads grafting. (A–D) Only epithelial growth
could be seen (no blastema formation). (A, B) Histological analysis. Large epithelial
growth could be seen, but no obvious mesenchymal extension could be seen. (C) Type I
collagen and nuclei were visualized (red). Nucleiwere counterstained byDAPI (blue). (D)
Faint Prrx-1 expressionwas noticed in the wound. (E, F) In a few cases, bump could be seen
despite GM6001 application. (E) Histological analysis. (F) in situ hybridization could show
faintPrrx-1expression.Asterisks indicatebeads.Dotted lines inC,DandF indicate theborder
of the epidermis. Scale bar in (A)=500 μm. Scale bar in (B)=300 μm. Scale bar in (C)=
200 μm. (A, E) and (B, D, F) are the same magniﬁcation, respectively. epi=epidermis.
Fig. 10. The induced bump by FGF2&8 beads grafting was transplanted into the cartilage
regenerating region. (A) Green ﬂuorescent-labeled bump cells were grafted onto a
cartilage regenerating region. A piece of bone was removed and the labeled cells were
inserted into the gap of the bone. (B, C) Alcian blue, hematoxylin, and eosin staining.
Section was made 20 days after the surgery. Regenerating cartilage can be seen. Lines in
B indicate the amputated ends of the bone. (C) is the higher magniﬁcation of (B). (D, E)
Green ﬂuorescent-labeled cells could be seen in the regenerating cartilage. Cartilage
was visualized by immunohistochemistry (red). (E) is higher magniﬁcation of (D).
Scale bar in A, B, C, D, and E is 5 mm, 500 μm, 300 μm, and 200 μm, respectively.
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of bump induction.
Finally, we examined the differentiation capability of the induced
bump cells by FGF2&8 bead grafting (Fig. 10). It has been considered
that blastema cells derived from dermal tissues are multipotent. They
can redifferentiate into multiple tissue lineages within a connective
tissue lineage, such as a cartilage cell, during limb regeneration
(Hirata et al., 2010; Kragl et al., 2009; Muneoka et al., 1986). We
isolated the induced bump mesenchyme and labeled it with green
ﬂuorescent Dye. Next, the labeled bump mesenchyme was grafted
into a region of regenerating cartilage (Fig. 10A). This assay was
previously reported as the bone excision model (Satoh et al., 2010a).
The previous report showed that regular blastema cells and ALM
blastema cells can participate into cartilage regeneration, although
differentiated dermal ﬁbroblasts cannot. If the induced bump cells
possess such ALM blastema/regular blastema features, the induced
bump cells should participate into cartilage regeneration. Sections
showed that the amputated bone was bridged by cartilage cells, which
were stained on Alcian blue staining (Fig. 10B, C). The cartilage-forming
region, where type II collagen was present, contained green-labeled
cells (Fig. 10D, E). Since the green ﬂuorescent dye labeling the cellular
membrane and type II collagen is an ECM protein, the red and green
signal did not overlap, but it was obvious that labeled cells participated
in cartilage formation. This result clearly indicates participation of the
271A. Satoh et al. / Developmental Biology 355 (2011) 263–274induced bump cells in cartilage regeneration and differentiation into
cartilaginous cells. We further investigated the ability of the induced
bump cells by FGF2&8 bead grafting (Fig. 11). Whether the induced
bump could participate in regular limb regeneration was examined.
Bump formation was induced by FGF2&8 bead grafting in a GFP
transgenic axolotl. The GFP bumpmesenchymewas transplanted into a
regular blastema at the medium bud stage (Fig. 11A–C). After 10 days,
GFP positive cells had expanded distally (Fig. 11B, C). The blastemawas
ﬁxed and sectioned to investigate cellular contributions (Fig. 11D–F).
Histological analysis revealed that cartilage had already developed in
the regenerate (Fig. 11D). Furthermore, immunohistochemical analysis
revealed that GFP-positive cells could be seen in the cartilage region,
where type II collagen was expressed (Fig. 11E). This is consistent with
the results shown in Fig. 10. In the distal region where most of the
blastemacellswereundifferentiated,GFP-positive cellsweredetectable,
although type II collagen had not yet developed (Fig. 11F). GFP-positive
cells could be seen from the proximal to the distal region of the
regenerate. These results indicate that the induced bump cells can
participate in regular limb regeneration. Considering these results
together with gene expression patterns, it is suggested that the induced
bump is an equivalent structure to an ALM blastema and a regular
blastema.
Discussion
We demonstrated that MMP activity and application of FGF2&8
supplement to a lateral skin wound were sufﬁcient to induce a bump
cell, which appears to be a blastema cell. The bump induction is
independent from nerves in our experiment. In other words, bump
induction was completed in an aneurogenic state. Since the
neurotrophic factor(s) controlling limb regeneration have not been
elucidated, limb regeneration under aneurogenic conditions has long
been attempted. Our study provides an understanding of the
involvement of neurotrophic factors and ﬁbroblast activation in
limb regeneration in urodele amphibians.
Neurogenic regulation during the early phase of limb regeneration
In ALM, a nerve participates in limb regeneration from the very
beginning. Three days after amputation, axons can be observed within
the overlying epithelium. The nerve secretes FGFs (Fig. 1C;Mullen et al.,
1996; Poulin and Chiu, 1995; Satoh et al., 2008b), and the overlyingFig. 11. The induced bump mesenchyme participated into regular limb regeneration. (A)
FGF2&8 induced bump cells, which grew in a GFP transgenic, were grafted into a medium
bud stage blastema. (B, C) GFP positive cells expanded distally 10 days after the grafting.
(C) higher magniﬁcation of the boxed region in B. (D) The blastema was sectioned and
stained by Hematoxylin, Eosin and Alcian blue. (E, F) Type II Collagen (red) and GFP
(green) were visualized by immunohistochemistry. Nuclei were stained by DAPI (blue).
(E) Bump cells differentiated into cartilage cells. (F) GFP positive cells could be seen in the
distal region, where differentiated cartilage cells did not exist. Scale bars in A and D are
2 mm. Scale bar in F is 200 μm. A and B are the same magniﬁcation. E and F are the same
magniﬁcation.epithelium receives them from the nerve in ALM (Fig. 2; Poulin et al.,
1993; Satoh et al., 2008b). The primary target of FGF secreted from the
nerve would be the overlying epithelium. Furthermore, Sp-9 is initiated
by nerve-secreted FGF (Satoh et al., 2008b). In this study, we reported
the regulation of Fgfr genes in anALMblastemaanda simple skinwound
(Fig. 1A, B); the expression of these genes was previously reported in a
regular limb blastema (D'Jamoos et al., 1998; Poulin et al., 1993). Fgfr-1
is dominantly expressed in the blastema mesenchyme, and Fgfr-2 is
mainly regulated by AEC in the blastema. Both genes are upregulated in
theD5ALMblastema (Fig. 1A, B). Given the Fgfrs expression pattern and
knowledge in limb development, presence of an Fgf-positive feedback
loop is suggested. In limb development in higher vertebrates, the FGF
feedback loop functions to grow the limb bud distally (Martin, 1998).
Limb regeneration is similar to limb development; therefore, the Fgf
feedback loop in axolotl limbregeneration shouldplaya role in blastema
growth. Nerves trigger the formation of the Fgf feedback loop because
there is no initial blastema mesenchyme at the very beginning of ALM.
During regeneration following limbamputation, dermalﬁbroblasts start
to migrate, dermal ﬁbroblasts start to migrate approximately 5 days
after amputation (Gardiner et al., 1986), therefore, nerve-secreted FGFs
are most likely to induce AEC formation and then AEC and/or nerves
induce blastema mesenchyme, secreting FGFs back to the AEC.
ECM reconstitution in wound healing and limb regeneration
The importance of ECM regulation has long been known. In our
sequence data, upregulation of the MMP genes was observed. Dermal
ﬁbroblasts, which produce a collagenmatrix to maintain skin structure,
are a major source of blastema cells (Muneoka et al., 1986). The dermis
cells are laid in a collagenmatrix, and some are embedded in a relatively
thick collagen layer in normal skin. In contrast, a blastema shows less
ECMstructures because there is higherMMPactivity (Fig. 6A, Stevenson
et al., 2006; Vinarsky et al., 2005; Yang and Bryant, 1994; Yang et al.,
1999), and observation with an electron microscope showed that even
the basal lamina between the blastemamesenchyme and AEC is absent
(Bryant et al., 1971). Basal lamina development appears to be related to
mesenchymal differentiation. In the differentiating blastema, the basal
lamina develops and dermis is formed in the proximal region, where
cellular differentiation occurs (Satoh et al., 2008a). In case of wound
healing, dermis differentiation starts from a relatively early phase as
comparedwith limb regeneration (Endoet al., 2004; Satoh et al., 2008a).
Collagen (dermis) regeneration and reorganization, including basal
lamina reformation, begin from the early phase of wound healing. The
differentiating dermal ﬁbroblasts express AmTwist and type I Collagen
deposits can be seen in the same region. However, when a nerve is
deviated andAEC is induced,AmTwist expression and collagen synthesis
are inhibited (Satoh et al., 2008a). Given that AEC, the nerve, and the
blastema mesenchyme form a positive feedback loop of FGFs, higher
MMP expressions should be maintained by the Fgf feedback loop in a
blastema. This is consistentwith the results shown in Fig. 4B. Other ECM
proteins have also been described (Klatt et al., 1992; Nace and Tassava,
1995; Onda et al., 1991; Stocum, 2004; Wei et al., 1995; Yang et al.,
1992). Tenascin-C (TN-C) is one of the earliest and the most abundant
blastemamarker genes in amphibian limb regeneration, and accelerates
cell migration (Onda et al., 1990, 1991). Fibroblasts around an
amputation or wound site should migrate toward the site where the
blastema grows. Interestingly, TN-C is regulated by Prrx-1 in higher
vertebrates (Ihida-Stansbury et al., 2004, 2005). Therefore, it is
reasonable that TN-C is positively regulated in the blastema. Fibronectin
is also upregulated in the blastema, and is synthesized in both AEC and
mesenchymal cells (Gulati et al., 1983; Nace and Tassava, 1995; Repesh
et al., 1982). Furthermore, in higher vertebrates, cell migration is
supported by Fibronectin during wound healing (Briggs, 2005). Toward
the endof limb regeneration, TN-C andFibronectin expression decreases
and ﬁbroblasts seem to differentiate into a mature state (Nace and
Tassava, 1995; Onda et al., 1991). To maintain appropriate conditions,
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degradation in limb regeneration.
Activation of dermal ﬁbroblasts
Dermal tissue can generate multipotent blastema cells. In this
study, we showed that Prrx-1, a blastema marker gene, was
upregulated in a skin tissue by collagenase treatment. In amphibian
limb regeneration, Prrx-1 expression was ﬁrst reported in the African
clawed frog (X. laevis),an anuran amphibian, and was found to be
upregulated in the regenerating blastema (Suzuki et al., 2005, 2007).
The similar Prrx-1activation could be detectable in axolotl, a urodele
amphibian (Satoh et al., 2007). In both amphibians, Prrx-1 expression
could not be detected in completely differentiated dermal ﬁbroblasts;
therefore, Prrx-1 would be proper to use as one of blastema marker
genes. We ﬁrst speculated that FGFs secreted from a nerve activated
Prrx-1 gene expression to induce formation of a blastema. However,
Prrx-1 was not induced by FGF2&8 supplement (Fig. 5A). This is
consistent with the observation that nerve deviation under mature
skin does not induce formation of a blastema (unpublished data).
Because FGFs seems not to be an inducer of limb regeneration, we
next focused on MMPs. Signiﬁcant differences in MMPs expression
could be detected in our sequence database and this was conﬁrmed by
qPCR (Fig. 6A, Table 1). It was reported that initial MMPs activities are
not nerve dependent although it is considered that maintenance of
MMP genes was nerve dependent (Yang et al., 1999; Yang and Bryant,
1994). In fact, the migrating epidermis starts expressing MMP-9 in
limb regeneration within 2 h (Ferris et al., 2010; Satoh et al., 2008b),
and many hematopoietic cells, such as microphages and neutrophils,
exhibit highMMP activity (Vihinen and Kahari, 2002). Therefore,MMP
activation occurs independently of the presence of a nerve in the early
phases. In later phases, MMP expression appears to be related to the
presence of a nerve. As shown in Fig. 6A,MMP activity is downregulated
in wounds andmaintained in blastemas. In the previous study, collagen
deposition was detected within 10 days of simple skin wounding,
indicating low MMP activity (Satoh et al., 2008a). In contrast, nerve
deviation to a wound inhibits such collagen deposition, suggesting that
nerves supportMMP activity (Satoh et al., 2008a). As mentioned above,
Fgfs are likely to be neurotrophic factors. We demonstrated that Fgfs
maintain collagenase and stromelysins inALMblastemacells (Fig. 4B).We
still do not knowwhether nerve-secreted or AEC-produced Fgfs support
MMP activity, but it is unsurprising that the blastema is rich in Fgfs. Such
an Fgf-rich environment maintains high MMP activity in the blastema.
MMPs target and subsequently degrade collagens in tissues. ECM
degradation can change TN-C gene expression, which is regulated by
Prrx-1 (Jones et al., 1999, 2001; McKean et al., 2003). In vascular cells,
Prrx-1 is potentially regulated by ECM degradation (Jones et al., 2001).
Cells plated on native collagen suppress the Prrx-1 gene, while cells
plated on heat-denatured collagen activate the Prrx-1 gene (Jones et al.,
2001). Therefore, it is unsurprising that axolotl ﬁbroblasts exhibit the
same regulatory systems. We also investigated the intracellular
regulatory mechanism (Fig. 7). The ALM blastema, which exhibits high
MMP activity, had relativelyhigh levels of pFAK. FAKcanact asa sensor of
ECM modiﬁcation (Wederell and de Iongh, 2006). Integrins are located
upstream of pFAK, and β1 integrin is downregulated in amphibian
regeneration blastemas (Tsonis et al., 1997) and β3 integrin is
upregulated in the ALM blastemas, as shown in Fig. 7B. This integrin
regulation is consistentwith our knowledge of vascular cells (Jones et al.,
1999). In axolotls, it is likely that intact ﬁbroblasts express β1 integrin to
maintain their attachment to ECM, and activated ﬁbroblasts change β1
integrin to β3 integrin to transduce signals to FAK. It is still not known
what these integrins bind to, but it is likely that natural collagens and
collagens degraded by MMPs are their targets. Collagenase treatment,
which would result in collagen degradation, somehow upregulated
Prrx-1 in our tissue culture experiment (Fig. 5B). However, the activated
Prrx-1 expression level was low compared with its expression in theblastema (Fig. 5B, C). We believe that continuous FGF input is necessary
to increase Prrx-1 expression. Unfortunately, we cannot examine our
hypothesis in vitro because the appropriate conditions for culturing
axolotl cells are not known and is difﬁcult to maintain axolotl cells in a
highly proliferative state since most cells undergo senescence within
several days and long-term cultivation is difﬁcult.
SU5402 applied to ALM blastema decreased Prrx-1 expression
(Fig. 4A). Therefore, it is suggested that Fgf signaling maintains Prrx-1
expression in coordination with MMP activity. It is still not known
whether Fgf signaling controls Prrx-1 expression through a modiﬁca-
tion of MMPsor a different signaling cascade is involved. Fibroblasts
are activated by ECM modiﬁcations and Fgf is active during the early
phases of limb regeneration. Prrx-1-positive cells derived from dermal
ﬁbroblasts may acquire multipotency during this activation process. It
is still not clear how ﬁbroblasts reprogram their cellular information,
such as their positional value; however, the activation process is now
partially unveiled.
Bump induction by FGF2&8-soaked gelatin beads in an aneurogenic
environment
The neurotrophic factor in amphibian limb regeneration has long
been a mystery. In this study, we succeeded in inducing a bump, which
has similar features to a regeneration blastema, in an aneurogenic
environment. Prrx-1 and Sp-9 expression patterns in the bump induced
by FGF-soaked beads were consistent with those in regular and ALM
blastemas (Fig. 8G–J, Satoh et al., 2008b, 2007). Moreover, the bump
cells induced by FGF2&8 bead grafting could participate in cartilage
regeneration and regular limb regeneration (Figs. 10 and 11). These
observations suggest that the induced bump is equivalent to a blastema.
We still do not know whether FGF2&8 acts as a nerve factor in limb
regeneration;however, it is likely that FGF2 is anerve factor because Fgf-
2 is expressed in nerves (Fig. 1C; Mullen et al., 1996). Fgf-8 is more
commonly regarded as an AER/AEC factor rather than as a neural factor
(Christen and Slack, 1997; Endo et al., 2000; Han et al., 2001; Mahmood
et al., 1995). However, itwas recently reported that Fgf-8was expressed
in DRG in mouse embryos (Tanaka et al., 2001). It is, therefore, possible
that FGF8works as a neural factor. The Fgf-8 expression pattern has been
reported in a regenerating amphibian blastema (Endo et al., 2000; Han
et al., 2001). The basal layer of the distal blastema epithelium expresses
Fgf-8; therefore, FGF2 and FGF8 are abundantly supplied from a nerve
and/or AEC. It is clear thatmany factors interact in a complexmanner in
the early phases of limb regeneration; therefore, nerve function, AEC
induction, and blastema cell induction should be considered together.
The bump cells induced FGF2&8 bead grafting could transdiffer-
entiate. As reported previously, when dermal ﬁbroblasts are dissociated
(ECM digestion) and grafted into a cartilage regenerating region, those
dermal ﬁbroblasts remain ﬁbroblastic and do not differentiate into
cartilage cells (Satoh et al., 2010a). This indicates that ECM degradation
alone cannot induce blastema cells. Further regulation would be
necessary for blastema cell induction. ECM digestion could activate
dermal ﬁbroblasts to express blastema marker gene (Fig. 5B). So, ECM
digestion would be sufﬁcient to activate ﬁbroblasts but insufﬁcient to
induce blastema cells.We speculate that activatedﬁbroblasts need to be
exposed to an FGF-rich ﬁeld created by nerves and AEC or other factors
in order to become blastema cell. Neural factors such as nAG, substance
P, and glial growth factormaybe involved in limb regeneration (Brockes
and Kintner, 1986; Globus et al., 1983; Kumar et al., 2007). These factors
may be involved in an induction of blastema cells.
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